Abstract

The Role of Thrombomodulin in Prostate Tumor Cell Migration Thrombomodulin (TM) is an endothelial transmembrane receptor that regulates coagulation by binding to thrombin and activating the protein C system. TM is also expressed by prostate cancer (CaP) cells. CaP associated TM activates the protein C system. We investigated if TM expressed by CaP cells may also be involved in tumor progression by determining its ability to regulate tumor cell migration. PC-3 and DU-145 CaP cell lines were incubated in a Boyden chamber in the presence and absence of monoclonal antibodies to each extracellular domain of TM and amount of cell migration determined. The extracellular domains of TM include an N-terminal lectin-like domain, six epidermal growth factor-like (EGF) domains, and a serine-threonine rich domain, which is differentially glycosylated with a chondroiten sulphate moiety. We determined that monoclonal antibodies to the chondroiten sulphate domain increased the ability of both PC-3 and DU-145 cell lines to migrate. We also investigated if CaP cell invasion was regulated by thrombin, protein C, and activated protein C. We determined that PC-3 and DU-145 cell migration was not regulated by these TM-associated proteins. We conclude that the chondroiten sulphate domain of CaP cell TM regulates cell migration. Funding Support: South Carolina NIH INBRE grant, Freedland Foundation, McKay Urology Endowment Fund

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call